Tag Archives: Acute decompensated heart failure

November, 2016

  • 9 November

    FDA Grants Orphan Drug Designation to Eloxx’s Enzyme Deficiency Drug

    NESS ZIONA, Israel and WALTHAM, Massachusetts, November 7, 2016 /PRNewswire/ — Eloxx Pharmaceuticals, a biotechnology company focused on discovery, development and commercialization of compounds for the treatment of genetic diseases caused by nonsense mutations, announced today that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) …

December, 2015

  • 11 December

    Cardiorentis’ ADHF Drug Receives Fast Track Status from the FDA

    ZUG, Switzerland, Dec. 11, 2015 /PRNewswire/ — Cardiorentis AG, a privately held biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track status to Ularitide, an investigational therapy for the treatment of acute decompensated heart failure (ADHF). The FDA’s Fast Track process is intended …